Halonext-S Ointment is a topical formulation containing Halobetasol propionate (0.05% w/w), a potent corticosteroid, combined with Salicylic Acid (6% w/w), a keratolytic agent. This combination is indicated for the treatment of various inflammatory and hyperkeratotic skin conditions such as psoriasis, eczema, and lichen planus. Halobetasol exerts strong anti-inflammatory, antipruritic, and vasoconstrictive effects by modulating the release of inflammatory mediators and suppressing immune responses in the affected skin areas. Salicylic Acid facilitates the removal of scales and promotes desquamation by softening and loosening keratin, enhancing the penetration and efficacy of Halobetasol. Halonext-S Ointment is applied topically to the affected area once or twice daily as prescribed by a healthcare professional. It is essential to use the ointment for the recommended duration to minimize potential adverse effects such as skin atrophy, telangiectasia, or systemic corticosteroid absorption. The ointment should be avoided on infected or broken skin and in patients with hypersensitivity to any of its components. Caution is advised in pediatric and elderly populations. Halonext-S Ointment provides an effective therapeutic option for managing chronic inflammatory dermatoses with hyperkeratosis, improving symptoms and skin appearance when used appropriately.